Abstract
Metabolic engineering seeks to redirect metabolic pathways through the modification of specific biochemical reactions or the introduction of new ones with the use of recombinant technology. Many of the chemicals synthesized via introduction of product-specific enzymes or the reconstruction of entire metabolic pathways into engineered hosts that can sustain production and can synthesize high yields of the desired product as yields of natural product-derived compounds are frequently low, and chemical processes can be both energy and material expensive; current endeavors have focused on using biologically derived processes as alternatives to chemical synthesis. Such economically favorable manufacturing processes pursue goals related to sustainable development and “green chemistry”. Metabolic engineering is a multidisciplinary approach, involving chemical engineering, molecular biology, biochemistry, and analytical chemistry. Recent advances in molecular biology, genome-scale models, theoretical understanding, and kinetic modeling has increased interest in using metabolic engineering to redirect metabolic fluxes for industrial and therapeutic purposes. The use of metabolic engineering has increased the productivity of industrially pertinent small molecules, alcohol-based biofuels, and biodiesel. Here, we highlight developments in the practical and theoretical strategies and technologies available for the metabolic engineering of simple systems and address current limitations.
Similar content being viewed by others
References
Bailey, J. E. (1991). Toward a science of metabolic engineering. Science, 252, 1668–1674.
Hutchinson, C. R. (1998). Combinatorial biosynthesis for new drug discovery. Current Opinion in Microbiology, 1(3), 319–329.
Jacobson, J. R., & Khosla, C. (1998). New directions in metabolic engineering. Current Opinion in Chemical Biology, 2, 133–137.
Keasling, J. D. (2010). Manufacturing molecules through metabolic engineering. Science, 330, 1355–1358.
Nerem, R. M. (1991). Cellualr engineering. Annals of Biomedical Engineering, 19, 529–545.
Koffas, M., Roberge, C., Lee, K., & Stephanopoulos, G. (1999). Metabolic engineering. Annual Review of Biomedical Engineering, 01, 535–557.
Price, N. D., et al. (2004). Genome-scale models of microbial cells: evaluating the consequences of constraints. Nature Reviews Microbiology, 2, 886–897.
Kosla, C., & Keasling, J. D. (2003). Metabolic engineering for drug discovery and development. Nature Reviews, 2, 1019–1024.
Van der Oost, J., Ciaramella, M., Moracci, M., Pisani, F. M., Rossi, M., & de Vos, W. M. (1998). Molecular biology of hyperthermophillic Archaea. Advances in Biochemical Engineering/Biotechnology, 61, 87–115.
Colon, G. E., Nguyen, T. T., Jetten, M. S. M., Sinskey, A. J., & Stephanopoulos, G. (1995). Production of isoleucine by overexpression of ilvA in a Corynebacterium lactofermentum threonine producer. Applied Microbiology and Biotechnology, 43, 482–488.
MacQuitty, J. J. (1988). Impact of biotechnology on the chemical industry. ACS Symposium Series, 362, 221–233.
Stephanopoulos, G. (1999). Metabolic fluxes and metabolic engineering. Metabolic Engineering, 1, 1–11.
Nielson, J. (1994). Physiological engineering-towards a new science, pp. 30–38. Proc. The 1994 IChemE Research Event, London.
Cameron, D. C., & Tong, I. T. (1993). Cellular and metabolic engineering. Applied Biochemistry and Biotechnology, 38, 105–140.
Hutchinson, C. R. (1994). Drug synthesis by genetically engineered microorganisms. Bio/Technology, 12, 375–380.
Craig, G. M., Newman, D. J., & Snader, K. M. (1997). Natural products in drug discovery and development. Journal of Natural Products, 60, 52–60.
McCaskill, D., & Croteau, R. (1997). Prospects for the bioengineering of isoprenoid biosynthesis. Advances in Biochemical Engineering/Biotechnology, 55, 107–146.
Yarmush, M. L., & Berthiaume, F. (1997). Metabolic engineering and human disease. Nature Biotechnology, 15, 525–528.
Maynard, N. D., Gutschow, M. V., Birch, E. W., & Professor, M. W. C. (2010). The virus as metabolic engineering. Biotechnology Journal, 5, 686–694.
Lee, S. Y., Kim, H. U., Park, J. H., Park, J. M., & Kim, T. Y. (2009). Metabolic engineering of microorganisms: general strategies and drug production. Drug Discovery Today, 14, 81–89.
Zhang, F., & Keasling, J. (2011). Biosensors and their applications in microbial metabolic engineering. Trends in Microbiology, 19, 323–329.
Shaw, A. J., Podkaminer, K. K., Desai, S. G., Bardsley, J. S., Rogers, S. R., Thorne, P. G., Hogsetti, D. A., & Lynd, L. R. (2008). Metabolic engineering of a thermophilic bacterium to produce ethanol at high yield. Proceedings of the National Academy of Sciences USA, 105, 13669–13774.
Haggart, C. R., Bartel, J. A., & Saucerman, J. J. (2011). Whole-genome metabolic network reconstruction and constraint-based modeling. Methods in Enzymology, 500, 411–433.
Chavali, A. K., D’Auria, K. M., & Hewlett, E. L. (2012). A metabolic network approach for the identification and prioritization of antimicrobial drug targets. Trends in Microbiology, 20, 113–123.
Stephanopoulos, G., & Simpson, T. W. (1997). Flux amplification in complex metabolic networks. Chemical Engineering Science, 52, 2607–2627.
Stephanopoulos, G., & Valino, J. J. (1991). Network rigidity and metabolic engineering in metabolite overproduction. Science, 252, 1675–1681.
Kacser, H., & Burns, J. A. (1973). The control of flux. Symposia of the Society for Experimental Biology, 27, 65–104.
Lee, J. M., Gianchandani, E. P., & Papin, J. A. (2006). Flux balance analysis in the era of metabolomics. Briefings in Bioinformatics, 7, 140–150.
Chang, M. C., & Keasling, J. D. (2006). Production of isoprenoid pharmaceuticals by engineered microbes. Nature Chemical Biology, 2, 674–681.
Palsson, B. (2006). Systems biology: properties of reconstructed networks. Cambridge University Press.
Delgado, J., & Liao, J. C. (1992). Metabolic control analysis from transient metabolite concentrations. Biochemical Journal, 282, 919–927.
Nielsen, J., & Jorgensen, H. S. (1995). Metabolic control analysis of biochemical pathways based on a thermokinetic description of reaction rates. Biochemical Journal, 321, 133–138.
Pissarra, P. N., Nielsen, J., & Bazin, M. J. (1996). Pathway kinetics and metabolic control analysis of high yielding strain of Penicillium chrysogenum during fed-batch cultivation. Biotechnology and Bioengineering, 51, 168–176.
Petterson, G. (1996). Errors associated with experimental determination of enzyme flux control coefficients. Journal of Theoretical Biology, 179, 191–197.
Rivera, S. J. B., Bennett, G. N., & San, K. Y. (2001). The effect of increasing NADH availability on the redistribution of metabolic fluxes in E. coli. Chemostat Cultures. Metabolic Engineering, 4, 230–237.
Yang, Y. T., Bennett, G. N., & San, K. Y. (1998). Genetic and metabolic engineering. Electronic Journal of Biotechnology, 1, 3.
Gillespie, D. T. (1976). A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. Journal of Computational Physics, 22, 403–434.
Mavelli, F. (2012). Stochastic simulations of minimal cells: the Rivocell models. BMC Bioinformatics, 13, S10.
Carletti, T., & Filisetti, A. (2012). The stochastic evolution of a protocell: the Gillespie algorithm in a dynamically varying volume. Computational and Mathematical Methods in Medicine, 20, 423627.
Huang, D., Jia, X., Wen, J., Wang, G., Yu, G., Caiyin, Q., & Chen, Y. (2011). Metabolic flux analysis and principal nodes identification for daptomycin production improvement by Streptomyces roseosporus. Applied Biochemistry and Biotechnology, 7-8, 1725–1739.
Schuetz, R., Zamboni, N., Zampieri, M., Heinemann, M., & Sauer, U. (2012). Multidimensional optimality of microbial metabolism. Science, 6081, 601–604.
Ay, F., Dang, M., & Kahveci, T. (2012). Metabolic network alignment in large scale by network compression (13): Suppl 3:S2.
Kern, A., Tilley, E., Hunter, I. S., Legisa, M., & Glieder, A. (2007). Engineering primary metabolic pathways of industrial microorganisms. J. Biotech, 1, 6–29.
Orman, M. A., Berthiaume, F., Androulakis, I. P., & Lerapetritou, M. G. (2011). Advanced stoichiometric analysis of metabolic networks of mammalian systems. Critical Reviews in Biomedical Engineering, 6, 511–534.
Wahrheit, J., Nicolae, A., & Heinzle, E. (2011). Eukaryotic metabolism: measuring compartment fluxes. Biotechnology Journal, 9, 1071–1085.
Nookaew, I., Olivares-Hernandez, R., Bhumiratana, S., & Nielsen, J. (2011). Genome-scale metabolic models of S. cerevisiae. Methods in Molecular Biology, 759, 445–463.
Noh, K., & Wiechert, W. (2011). The benefit of being transient: isotope-based metabolic flux analysis at the short time scale. Applied Microbiology and Biotechnology, 5, 1247–1265.
Price, N. D., & Kim, P. J. (2010). Macroscopic kinetic effect of cell to cell variation in biochemical reactions. Physical Review Letters, 104, 148103.
Kravchenko-Balasha, N., Levitzki, A., Goldstein, A., Rotter, V., Gross, A., Remacle, R., & Levine, R. D. (2012). On the fundamental structure of gene networks in living cells. Proceedings of the National Academy of Sciences USA, 12, 4702–4707.
Kravchenko-Balasha, N., LRemacle, F., Gross, A., Rotter, V., Levitzki, A., & Levine, R. D. (2011). Convergence of logic of cellular regulation in different premalignant cells by an information theoretical approach. BMC Systems Biology, 5, 42.
Han, M. J., Lee, S. Y., Koh, S. T., Noh, S. G., & Han, W. H. (2010). Biotechnological applications of microbial proteomes. Journal of Biotechnology, 4, 314–319.
Jensen, P.R., & Hammer, K. (1998). Artificial promoters for metabolic optimization (2–3):191–5.
Weeks, A. M., & Chang, M. C. (2011). Constructing de novo biosynthetic pathways for chemical synthesis inside living cells. Biochemistry, 24, 5404–5418.
Chemlet, J. A., & Koffas, M. A. (2008). Metabolic engineering for plant natural product biosynthesis in microbes. Current Opinion in Biotechnology, 6, 597–605.
Mitchell, W. (2011). Natural products from synthetic biology. (4):505–15.
White, N. J. (2008). Qinghaosu (Artemisinin): the price of success. Science, 18, 330–334.
Madduri, K., Kennedy, J., Rivola, G., Inventi-Solari, A., & Fillippini, S. (1998). Production of the antitumor drug epirubicin (4′-epidoxorubicin) and its precursor by a genetically engineered strain of S. peucetius. Nature Biotechnology, 16, 69–74.
Nicolaou, K.C., Yang, Z., Liu, J.J., & Ueno, H. (1994). Total synthesis of taxol (367):630–634.
McDaniel, R., Ebert-Khosla, S., Hopwood, D. A., & Khosla, C. (1993). Engineering biosynthesis of novel polyketides. Science, 262, 1547–1550.
Pitera, D. J., Paddon, C. J., Newman, C. J., & Keasling, J. D. (2007). Balancing a heterologous mevalonate pathway for improved isoprenoid production in E. Coli. Metabolic Engineering, 9, 193–207.
Martin, V. J., Pitera, D. J., Withers, S. T., Newman, J. D., & Keasling, J. D. (2003). Engineering a mevalonate pathway in E. coli for production of terpenoids. Nature Biotechnology, 21, 796–802.
Leonard, E., & Koffas, M. A. (2007). Engineering of artificial plant cytochrome P450 enzymes for synthesis of isoflavones by E. Coli. Applied and Environmental Microbiology, 73, 7246–7251.
Jung, W. S., Lee, S. K., Hong, J. S. J., Park, S. R., Jeong, S. J., Han, A. R., Sohng, J. K., Kim, B. G., Choi, C. Y., & Sherman, D. H. (2006). Heterologous expression of tylosin polyketide synthase and production of a hybrid bioactive macrolide in Streptomyces venezuelae. Applied Genetics and Molecular Biotechnology, 72, 763–769.
Lum, A. M., Huang, J., Hutchinson, C. R., & Kao, C. M. (2004). Reverse engineering of industrial pharmaceutical-producing actinomycete strains using DNA microarrays. Metabolic Engineering, 3, 186–196.
Butler, A. R., & Cundliffe, E. (2001). Influence of dimethylsulfoxide on tylosin production in Streptomyces fradiae. Journal of Industrial Microbiology and Biotechnology, 27, 46–51.
Shang, K., Hu, Y., Zhu, C., & Zhu, B. (2008). Production of 4′-epidaunorubicun by metabolic engineering of Streptomyces coeruleorubidus strain SIPI-1482. World Journal of Microbiology and Biotechnology, 24, 1107–1113.
Pfiefer, B. A., Admiraal, S. J., Gramajo, H., Cane, D. E., & Khosla, C. (2001). Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science, 291, 1790–1792.
Vadali, R. V., Bennett, G. N., & San, K. Y. (2004). Cofactor engineering of intracellular CoA/acetyl-CoA and its effect on metabolic flux redistribution in E. coli. Metabolic Engineering, 2, 133–139.
Kinoshita, S., Nakayama, K., & Kitada, S. (1958). l-Lysine production using microbial auxotroph. J. Gen. Appl. Microbiol.
Dikshit, K. L., & Webster, D. A. (1988). Cloning, characterization and expression of the bacterial globin gene from Vitreoscilla in E. Coli. Gene, 70, 377–386.
Brabetz, W., Liebl, W., & Schleifer, K. H. (1991). Studies on the utilization of lactose by Corynebacterium glutamicum, bearing the lactose operon of Escherichia coli. Archives of Microbiology, 155, 607–612.
Cameron, D. C., Altaras, N. E., Hoffman, M. L., & Shaw, A. J. (1998). Metabolic engineering of propanediol pathways. Biotechnology Progress, 14, 116–125.
Fussenegger, M., Schlatter, S., Datwyler, D., Mazur, X., & Bailey, J. (1998). Controlled proliferation by multi-gene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nature Biotechnology, 16, 468–472.
Dunlop, M. J., Keasling, J. D., & Mukhopadhyay, A. (2010). A model for improving microbial biofuel production using a synthetic feedback loop. Systems and Synthetic Biology, 2, 95–104.
Salas, J. A., & Mendez, C. (1998). Genetic manipulation of antitumor-agent biosynthesis to produce novel drugs. Trends in Biotechnology, 16, 475–482.
Zadran, S., Qin, Q., Bi, X., Zadran, H., Kim, Y., Foy, M. R., Thompson, R., & Baudry, M. (2009). 17-Beta-estradiol increases neuronal excitability through MAP kinase-induced calpain activation. Proceedings of the National Academy of Sciences of the United States of America, 106(51), 21936–21941.
Conflict of interest
Authors declare no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zadran, S., Levine, R.D. Perspectives in Metabolic Engineering: Understanding Cellular Regulation Towards the Control of Metabolic Routes. Appl Biochem Biotechnol 169, 55–65 (2013). https://doi.org/10.1007/s12010-012-9951-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-012-9951-x